The JAK/STAT signaling axis is a key modulator of cytokine signaling and one proposed mechanism for aberrant STAT3 activation in lung cancer involves the upregulation of autocrine and/or paracrine IL-6 signaling [2]. This evidence concerns the gene IL6 and lung carcinoma.